INS and type 2 diabetes mellitus: Our results demonstrate that the WAT CK2 amount and activity observed in the different groups of BMI-matched obese patients are higher than in normal-weight controls, independently of IR severity, early glycemia alterations, overt T2D or different levels of WAT insulin-sensitivity (Fig. 7).